CCND1 Stability Regulated by USP7 Deubiquitination Controls Glioma Radioresistance via Ferroptosis
Analytical Cellular Pathology · 2026
DOI: 10.1155/ancp/1041908 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Cellular Pathology, 2026. Verfasst von Yayu Zhuo und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, Hebei, China, hebmu.edu.cn. Hauptthemen laut MEDLINE: Glioma, Ubiquitin-Specific Peptidase 7, Cyclin D1, Radiation Tolerance. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Hebei Province, Hebei Provincial Health Commission Medical Research Project.
Abstract (Originalsprache)
Dysregulation of Cyclin D1 (CCND1) is implicated in various cancers, but its specific contribution to glioma radioresistance and the associated regulatory mechanisms remain largely unexplored. This research aimed to elucidate the functional role and underlying mechanisms of CCND1 in glioma radioresistance. Our findings revealed that CCND1 is significantly upregulated in glioma tissues, which correlates with a poor prognosis. Furthermore, CCND1 knockdown inhibited proliferation, triggered apoptosis, and augmented radiosensitivity in glioma cells. Additionally, CCND1 depletion sensitized glioma cells to irradiation by driving ferroptosis, as indicated by elevated reactive oxygen species (ROS) production, lipid peroxidation, and intracellular Fe 2+ accumulation. Mechanistically, USP7 was identified to stabilize the CCND1 protein via K48‐linked deubiquitination. Notably, the ectopic expression of USP7 reversed the impacts of CCND1 knockdown on radiosensitivity, ferroptosis, cellular proliferation, and apoptosis. Altogether, our data indicate that the stabilization of CCND1 mediated by USP7 promotes radioresistance in glioma by suppressing ferroptosis. Therefore, targeting USP7 may serve as a promising therapeutic approach to augment the efficacy of radiotherapy in glioma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, Hebei, China, hebmu.edu.cn.
- Department of Thyroid and Breast Surgery, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, Hebei, China, hebmu.edu.cn.
- The Second Hospital of Hebei Medical University, Shijiazhuang 050000, Hebei, China, hebmu.edu.cn.
- Shenze County People's Hospital, Shijiazhuang 050000, Hebei, China.
- Xingtang County Chinese Medicine Hospital, Shijiazhuang 050000, Hebei, China.
ORCID-Profile: Yayu Zhuo, Chenrui Zhang, Xiaoyu Li, Zishuo Du, Yiren Rong, Di Zhang, Haijuan Mi, Xiaoyu Gu, Feng Wang, Haie Han, Jianliang Wu, Jianping Sun
Förderung
- Natural Science Foundation of Hebei Province
- Hebei Provincial Health Commission Medical Research Project
Zitieren
APA
Zhuo, Y., Zhang, C., Li, X., Du, Z., Rong, Y., Zhang, D., Mi, H., Gu, X., Wang, F., Han, H., Wu, J., & Sun, J. (2026). CCND1 Stability Regulated by USP7 Deubiquitination Controls Glioma Radioresistance via Ferroptosis. Analytical Cellular Pathology. https://doi.org/10.1155/ancp/1041908
Vancouver
Zhuo Y, Zhang C, Li X, Du Z, Rong Y, Zhang D, et al. CCND1 Stability Regulated by USP7 Deubiquitination Controls Glioma Radioresistance via Ferroptosis. Analytical Cellular Pathology. 2026. doi:10.1155/ancp/1041908
BibTeX
@article{Zhuo2026,
author = {Zhuo, Yayu and Zhang, Chenrui and Li, Xiaoyu and Du, Zishuo and Rong, Yiren and Zhang, Di and Mi, Haijuan and Gu, Xiaoyu and Wang, Feng and Han, Haie and Wu, Jianliang and Sun, Jianping},
title = {CCND1 Stability Regulated by USP7 Deubiquitination Controls Glioma Radioresistance via Ferroptosis},
journal = {Analytical Cellular Pathology},
year = {2026},
doi = {10.1155/ancp/1041908}
}
EUVIMED